| 04:52 PM |
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
|
| 11:10 AM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 05:23 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 04:17 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:01 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 10:38 PM |
Disclosure Under Regulation 31(4) Of The SEBI (Substantial Acquisition Of Shares And Takeover Regulations, 2011)
|
| 01:28 PM |
Board Meeting Intimation for Intimation Of Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') And Closure Of Trading Window.
|
| 01:25 PM |
Closure of Trading Window
|
| 09:00 PM |
Intimation Of The Receipt Of Delhi High Court Order Admitting Company Petition In The Matter Of Novartis India Limited Vs. Commissioner Of Trade And Taxes (W.P.(C) 3892/2026)
|
| 03:51 PM |
Intimation Under Reg 30 Of SEBI LODR Of Receipt Of TDS Order As Per Income Tax Act
|
| 11:47 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 10:55 AM |
Announcement under Regulation 30 (LODR)-Cessation
|
| 10:49 AM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 10:42 AM |
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held Today I.E. Friday, March 27, 2026.
|
| 08:09 PM |
Intimation Of Receipt Of Draft Letter Of Offer Received From Manager To Open Offer (Axis Capital Limited).
|
| 12:05 PM |
Draft Letter of Offer
|
| 06:14 PM |
Detailed Public Statement
|
| 04:16 PM |
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
|
| 07:59 AM |
Open Offer - Public Announcement
|
| 12:29 AM |
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer
|
| 12:04 AM |
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
|
| 11:55 PM |
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
|
| 03:03 PM |
Rumour verification - Regulation 30(11)
|
| 02:43 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 02:14 PM |
Integrated Filing (Financial) For The Quarter Ended December 31, 2025.
|
| 01:51 PM |
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited ('The Company') Held On Wednesday, January 28, 2026.
|
| 03:34 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 04:36 PM |
Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Novartis India Limited To Inter Alia, Consider And Approve The Unaudited Financial Results For Quarter Ended December 31, 2025.
|
| 04:29 PM |
Closure of Trading Window
|
| 08:54 PM |
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (The 'Listing Regulations')
|
| 08:45 PM |
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
|
| 03:48 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 03:43 PM |
Integrated Unaudited Financial Results And Limited Review Report For The Quarter And Half-Year Ended September 30, 2025.
|
| 03:05 PM |
Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, October 28, 2025
|
| 04:03 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 02:39 PM |
Board Meeting Intimation for Inter Alia Considering The Unaudited Financial Results For The Half Year And Quarter Ended September 30, 2025.
|
| 02:18 PM |
Closure of Trading Window
|
| 07:21 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
|
| 08:09 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 06:26 PM |
Announcement under Regulation 30 (LODR)-Change in Management
|
| 05:10 PM |
Unaudited Financial Results For The Quarter Ended As On June 30, 2025.
|
| 04:37 PM |
Board Meeting Outcome for Intimation About The Outcome Of The Board Meeting Held On July 29, 2025, Inter Alia For The Approval Of Unaudited Financial Statements For The Quarter Ending As On June 30, 2025.
|
| 12:49 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 10:25 PM |
Intimation About The 77Th Annual General Meeting ("AGM") And Weblink Of The Annual Report For F.Y 2024-25 Of The Novartis India Limited ("The Company") To The Shareholders By Way Of Physical Dispatch Of Letters
|
| 10:49 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 09:44 PM |
Business Responsibility and Sustainability Reporting (BRSR)
|
| 08:24 PM |
Reg. 34 (1) Annual Report.
|
| 08:16 PM |
77Th Annual General Meeting Of Novartis India Limited To Be Held On Thursday, July 31, 2025, Through Video Conferencing (VC) / Other Audio Visual Means (OAVM)
|
| 10:53 PM |
The Intimation Is Submitted To Update That Communication Is Sent On Email To The Shareholders Regarding The Tax Deduction At Source On The Dividend If Approved At The Ensuing Annual General Meeting To Be Held On Thursday, July 31, 2025
|
| 09:23 PM |
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
|
| 09:20 PM |
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
|
| 04:52 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 11:50 AM |
Compliances-Reg.24(A)-Annual Secretarial Compliance
|
| 03:05 PM |
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
|
| 01:12 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 04:20 PM |
Intimation For Fixing The Record Date
|
| 02:05 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 01:54 PM |
Intimation Of Book Closure Date
|
| 01:53 PM |
Intimation Of Book Closure Date
|
| 01:48 PM |
Corporate Action-Board approves Dividend
|
| 01:17 PM |
The Board Has Approved The Re-Appointment Of Mr. Sanker Parameswaran (DIN:- 00008187) As An Independent Director For Second (02Nd) Term Of Five (5) Years Subject To The Approval Of The Members.
|
| 12:01 AM |
Appointment Of Secretarial Auditor For A Term Of Five (5) Consecutive Years Subject To Shareholders Approval At The Ensuing AGM
|
| 09:05 PM |
Integrated Filing (Financial)
|
| 08:29 PM |
Financial Results For The Quarter And Year Ended As On March 31, 2025
|
| 07:12 PM |
Board Meeting Outcome for Approval Of The Financial Statements For The Quarter And Financial Year Ended March 31, 2025 Along With The Audit Report And Declaration Of Dividend
|
| 10:51 PM |
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
|
| 09:36 PM |
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
|
| 12:42 PM |
Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011.
|
| 09:17 PM |
Filing Of Intimation Under Regulation 30 For The Receipt Of Draft Tax Assessment Order By The Company
|
| 06:22 PM |
Board Meeting Intimation for The Meeting Of The Board Of Directors Of The Company Is Scheduled To Be Held On Friday, May 09, 2025.
|
| 05:58 PM |
Closure of Trading Window
|
| 01:37 PM |
Integrated Filing (Financial)
|
| 07:14 PM |
This Is To Inform That The Company Has Received Order From Assistant Commissioner Of CGST And Central Excise And Disclosure Is Given Pursuant To Regulation 30 Read With Clause 20 Of Para A Of Schedule III
|
| 03:24 PM |
Announcement under Regulation 30 (LODR)-Newspaper Publication
|
| 01:18 PM |
Filing Of Unaudited Financial Results And Limited Review Report For The Quarter And Nine Months Ended December 31, 2024
|
| 01:07 PM |
Board Meeting Outcome for Filing Of Outcome Of The Meeting Of Board Of Directors Of Novartis India Limited Held On January 28, 2024
|
© 2026 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback